Comparability of venous versus capillary hemoglobin A1c measurements
Diabetology International · 2026-07 · 17 (3)
DOI: 10.1007/s13340-026-00889-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetology International, online erschienen am 22.04.2026. Verfasst von Em Yunir und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Me…. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Hemoglobin A1c (HbA1c) level measurement using venous blood sample is essential for diabetes management. However, this method is not always readily accessible in primary health care in Indonesia. This study aimed to evaluate the comparability of venous versus capillary blood HbA1c measurement.
Methods
A cross-sectional study was performed, involving subjects with and without type 2 diabetes (T2D). Venous blood samples were analyzed using a high-performance liquid chromatography (HPLC) analyzer. Simultaneously, capillary blood samples from the same subjects were analyzed using a point-of-care testing (POCT) instrument based on capillary electrophoresis (CE). Passing-Bablok regression was performed to assess constant or proportional bias between methods. Bland-Altman test was conducted to evaluate the agreement of HbA1c measurement between venous and capillary.
Results
Out of 162 subjects, 129 (79.6%) had diabetes, 9 (5.5%) had newly developed diabetes, and 24 (14.8%) did not have diabetes. Mean venous HbA1c was higher (7.79%) than capillary HbA1c (7.49%). Bland-Altman analysis showed that mean bias for all subjects was -0.30%, with 93.8% of subjects within the limit of agreement. Besides, mean bias between subjects with venous HbA1c < 6.5% and ≥ 6.5% was - 0.14% and -0.38%, respectively. Meanwhile, Passing-Bablok regression showed no constant and proportional bias in subjects with venous HbA1c < 6.5%. However, constant and proportional bias were found in all subjects and in those with venous HbA1c ≥ 6.5%.
Conclusions
Capillary HbA1c results have a good agreement with venous HbA1c. Capillary HbA1c POCT method can be considered as an alternative for monitoring diabetes. HbA1c measurement ≥ 6.5% should be interpreted with caution. Supplementary Information: The online version contains supplementary material available at 10.1007/s13340-026-00889-3.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jalan Diponegoro No. 71, 10430 Jakarta,…
- Metabolic Disorder, Cardiovascular and Aging Cluster,Faculty of Medicine Universitas Indonesia, Indonesian Medical Education and Research Institute, Jalan Salemba Raya No. 6, 10430 Jakarta, Indonesia.
- Department of Clinical Pathology,Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jalan Diponegoro No. 71, 10430 Jakarta, Indonesia.
Zitieren
APA
Yunir, E., Wafa, S., Indrasari, N. D., Iswati, E., Christabel, E. V., Widiyanti, D., Wisnu, W., Kurniawan, F., Amalina, N., Pradnjaparamita, T., Tahapary, D. L., & Tarigan, T. J. E. (2026). Comparability of venous versus capillary hemoglobin A1c measurements. Diabetology International, 17(3). https://doi.org/10.1007/s13340-026-00889-3
Vancouver
Yunir E, Wafa S, Indrasari ND, Iswati E, Christabel EV, Widiyanti D, et al. Comparability of venous versus capillary hemoglobin A1c measurements. Diabetology International. 2026;17(3). doi:10.1007/s13340-026-00889-3
BibTeX
@article{Yunir2026,
author = {Yunir, Em and Wafa, Syahidatul and Indrasari, Nuri Dyah and Iswati, Eni and Christabel, Eunike V and Widiyanti, Delina and Wisnu, Wismandari and Kurniawan, Farid and Amalina, Nida and Pradnjaparamita, Tika and Tahapary, Dicky L and Tarigan, Tri Juli Edi},
title = {Comparability of venous versus capillary hemoglobin A1c measurements},
journal = {Diabetology International},
year = {2026},
volume = {17},
number = {3},
doi = {10.1007/s13340-026-00889-3}
}
EUVIMED